Chongqing Winbond Pharmaceutical Co., Ltd. is located in Chongqing High-tech Development Zone. Is a joint-stock high-tech pharmaceutical enterprise with a registered capital of1320,000, nearly 600 employees and total assets of several hundred million yuan.
Winbond is a national key high-tech enterprise. Since its establishment, Winbond Pharmaceutical has set the goal of "scientific career", taking scientific research and new drug development as the foundation for enterprises to settle down, and taking high technology, high standards and specialization as the core competitiveness for enterprises to meet challenges. After ten years of unremitting efforts, Winbond has established a good corporate brand image in the fields of dermatology and tuberculosis treatment, and has become a professional manufacturer of R&D, production and sales of retinoic acid drugs.
In the process of diversified development related to the pharmaceutical industry, Winbond Pharmaceutical implements a high-level development strategy based on the pharmaceutical industry, linked by the industrial chain, market-oriented, supported by science and technology, based on talents, and relying on product management and capital management to build the core competitiveness of enterprises. Winbond Pharmaceutical has successively set foot in tourism, energy industry and pharmaceutical industry by holding shares, and invested in the construction of Chongqing Han Bang Natural Pharmaceutical Co., Ltd., Chongqing Huibang Tourism Co., Ltd., Chongqing Winbond Hotel Tourism Co., Ltd. and Chongqing Winbond Energy Technology Co., Ltd., thus taking a strategic step of "concentric diversification and developing the future".